Cardiol Therapeutics Inc.
Biotechnology company · Oakville, Ontario, Canada · Nasdaq: CRDL
Cardiol Therapeutics Inc. is a biotechnology company headquartered in Oakville, Ontario, Canada. Its earliest recorded incorporation is in 2017. Its shares trade on Nasdaq under the ticker CRDL. It has reported private securities offerings to the US SEC, most recently $829,139 sold in a notice filed in 2020.
Cardiol Therapeutics at a glance
What does Cardiol Therapeutics do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $829,139 sold (2020).
Frequently asked questions about Cardiol Therapeutics
Where is Cardiol Therapeutics headquartered?
Cardiol Therapeutics Inc. is headquartered in Oakville, Ontario, Canada.
What does Cardiol Therapeutics do?
Cardiol Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is Cardiol Therapeutics a public company?
Yes. Cardiol Therapeutics Inc. trades on Nasdaq under the ticker CRDL.
When was Cardiol Therapeutics founded?
The earliest incorporation on record for Cardiol Therapeutics Inc. is in 2017, according to public company registers.
Similar companies
- Aptose Biosciences Inc.Toronto, Ontario, Canada
- Orion Biotechnology Canada Ltd.Ottawa, Ontario, Canada
- enGene Therapeutics Inc.Saint-Laurent, Quebec, Canada
- ARC Medical Inc.Richmond, British Columbia, Canada
- Zucara Therapeutics Inc.Toronto, Ontario, Canada
- Soricimed Biopharma Inc.Moncton, New Brunswick, Canada
- Appili Therapeutics Inc.Halifax, Nova Scotia, Canada
- Therma Bright Inc.Toronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences